Celltrion, Incorporation operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Celltrion, Incorporation with three other
pharmaceutical manufacturers in Asia:
sales of 34.85 billion Indian Rupees [US$541.98 million]
of which 69%
China Animal Husbandry Ind.
(3.97 billion Chinese Renmimbi [US$589.08 million]
of which 48%
was Animal Feedstuff), and
Yifan Pharmaceutical Co Ltd
based in China
(3.50 billion Chinese Renmimbi [US$519.42 million]
of which 67%
was Health Products - Medicine).
Celltrion, Incorporation reported sales of 670.58 billion Korean Won (US$596.15 million)
December of 2016.
increase of 11.1%
versus 2015, when the company's sales were 603.41 billion Korean Won.
This was the third consecutive year of growth at Celltrion, Incorporation.
Sales of Chemical Business Division saw an increase
that was more than double the company's growth rate: sales were up
39.9% in 2016, from
72.58 billion Korean Won to 101.57 billion Korean Won.